Women with ERα-negative BC display a significantly increased relapse-free survival (RFS) only when the tumor expresses low levels of ATP1A1 (Figure 4A,C,E,F; see also Supplementary Table S4). This evidence concerns the gene ATP1A1 and breast cancer.